Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Nanna

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Heart (British Cardiac Society)|March 4, 2025
Moving towards precision medicine for older adults with non-ST-segment elevation myocardial infarctionArmin Nouri, Michael G Nanna
Journal of the American College of Cardiology|July 24, 2024
Searching for Meaning: Refining Troponin Thresholds to Align Risks Between Spontaneous and Procedural Myocardial InfarctionMichael G Nanna, Sridhar Mangalesh
JAMA Network Open|October 11, 2024
Validating the PREVENT Equations-A Contemporary Update to Cardiovascular Risk AssessmentSridhar Mangalesh, Michael G Nanna
JAMA|September 18, 2024
Prognostic Value of Cardiovascular BiomarkersSridhar Mangalesh, Michael G Nanna
JAMA Cardiology|December 10, 2025
Lipoprotein(a) Elevation for Refining Risk Stratification With the PREVENT EquationsSridhar Mangalesh, Michael G Nanna
The American Journal of Cardiology|August 10, 2023
Obesity and Undernutrition in Acute Myocardial InfarctionSridhar Mangalesh, Michael G Nanna
Heart (British Cardiac Society)|June 11, 2025
Reshaping the paradigm: towards holistic cardiovascular risk assessment in older adultsRaiza Rossi, Michael G Nanna
Journal of the American College of Cardiology|April 26, 2023
Stable Coronary Artery Disease in the Age of Geriatric CardiologyParag Goyal, Michael G Nanna
Annals of Internal Medicine|October 19, 2020
In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrelMichael G Nanna, Christopher B Granger
The Canadian Journal of Cardiology|August 9, 2021
Rise of the Machines: Where Virtual Processing Meets Percutaneous Coronary InterventionMichael G Nanna, W Schuyler Jones
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Heart (British Cardiac Society)|March 4, 2025
Moving towards precision medicine for older adults with non-ST-segment elevation myocardial infarctionArmin Nouri, Michael G Nanna
Journal of the American College of Cardiology|July 24, 2024
Searching for Meaning: Refining Troponin Thresholds to Align Risks Between Spontaneous and Procedural Myocardial InfarctionMichael G Nanna, Sridhar Mangalesh
JAMA Network Open|October 11, 2024
Validating the PREVENT Equations-A Contemporary Update to Cardiovascular Risk AssessmentSridhar Mangalesh, Michael G Nanna
JAMA|September 18, 2024
Prognostic Value of Cardiovascular BiomarkersSridhar Mangalesh, Michael G Nanna
JAMA Cardiology|December 10, 2025
Lipoprotein(a) Elevation for Refining Risk Stratification With the PREVENT EquationsSridhar Mangalesh, Michael G Nanna
The American Journal of Cardiology|August 10, 2023
Obesity and Undernutrition in Acute Myocardial InfarctionSridhar Mangalesh, Michael G Nanna
Heart (British Cardiac Society)|June 11, 2025
Reshaping the paradigm: towards holistic cardiovascular risk assessment in older adultsRaiza Rossi, Michael G Nanna
Journal of the American College of Cardiology|April 26, 2023
Stable Coronary Artery Disease in the Age of Geriatric CardiologyParag Goyal, Michael G Nanna
Annals of Internal Medicine|October 19, 2020
In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrelMichael G Nanna, Christopher B Granger
The Canadian Journal of Cardiology|August 9, 2021
Rise of the Machines: Where Virtual Processing Meets Percutaneous Coronary InterventionMichael G Nanna, W Schuyler Jones
Pageof 20